Montenegro vs New Zealand: Treatment success rate for patients treated for MDR-TB
Montenegro
100.0%
in 2018
New Zealand
100.0%
in 2022
Montenegro rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Montenegro
- New Zealand
How they compare
Montenegro currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 4 times across 7 shared years of data; in 2007 it was New Zealand ahead.
Montenegro ranks 1st and New Zealand ranks 1st of 163 countries.
Across the 2 decades both report, Montenegro averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Montenegro | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 46.5% | 3.5% | Montenegro |
| 2010s | 60.0% | 61.6% | 1.6% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Montenegro or New Zealand?
- Montenegro, at 100.0% against 100.0% in New Zealand as of 2018.
- What is the difference in treatment success rate for patients treated for mdr-tb between Montenegro and New Zealand?
- 0.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and New Zealand?
- 7 years are reported by both, from 2007 to 2018.
- How do Montenegro and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Montenegro ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.